Venture • Life Science

Eight Roads Invests In Dimension Therapeutics

On October 30, 2013, private equity firm Eight Roads invested in life science company Dimension Therapeutics

Investment Context

This is Eight Roads’ 24th transaction in the Life Science sector.
This is Eight Roads’ 30th transaction in the United States.
This is Eight Roads’ 12th transaction in Massachusetts.

Investment Fate

Dimension Therapeutics was sold to a publicly-traded strategic buyer in 2017 for 151M USD.

Explore All 557 Venture Life Science Deals - Search the Database Free

Investment Summary
Date	October 30, 2013
Target	Dimension Therapeutics
Sector	Life Science
Investor(s)	Eight Roads
Deal Type	Venture

Target Company

Dimension Therapeutics

Cambridge, Massachusetts, United States

Dimension Therapeutics is a developer of new therapeutic products for people living with devastating rare and metabolic diseases associated with the liver, based on the most advanced mammalian adeno-associated virus (AAV) gene delivery technology. Dimension Therapeutics was founded in 2013 and is based in Cambridge, Massachusetts.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor

Category	Private Equity Firm
Founded	1969
PE ASSETS	11.0B USD
Size	Mega
Type	Sector Focused

DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

Deal Context for Investor	#
Overall	69 of 293
Sector: Life Science	24 of 73
Type: Venture	54 of 266
State: Massachusetts	12 of 33
Country: United States	30 of 119
Year: 2013	14 of 14

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2013-08-26	Mtime.com China Mtime.com is a China’s most influential online media outlet and e-commerce service platform for films. With 160 million unique visitors per month and still growing, Mtime is the most influential online media outlet and e-commerce service platform for films in China. Additionally, Mtime designs, manufactures and sells high-end movie merchandise derived from one of the largest licensed movie IP portfolios in the world. Mtime.com was founded in 2005 and is based in China.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2013-08-26

Mtime.com

China

Mtime.com is a China’s most influential online media outlet and e-commerce service platform for films. With 160 million unique visitors per month and still growing, Mtime is the most influential online media outlet and e-commerce service platform for films in China. Additionally, Mtime designs, manufactures and sells high-end movie merchandise derived from one of the largest licensed movie IP portfolios in the world. Mtime.com was founded in 2005 and is based in China.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2013-11-25	Liazon New York, New York, United States Liazon operates Bright Choices exchange, an online private benefits exchange for businesses in the United States. Liazon was founded in 2007 and is based in New York City.	Sell	$215M

DATE

TARGET

DEAL TYPE

VALUE

2013-11-25

Liazon

New York, New York, United States

Liazon operates Bright Choices exchange, an online private benefits exchange for businesses in the United States. Liazon was founded in 2007 and is based in New York City.

Sell

$215M

Explore Related M&A Activity

Life Science M&A - Venture M&A Deals - Massachusetts M&A - United States M&A - 2013 M&A